Locomotor sensitization to [D-Trp11]neurotensin after repeated injections of the dopamine uptake inhibitor GBR12783 in rats

Neuroscience Letters

Volumn 208, Issue 1, 1996, Pages 5-8

  Boulay, D ^a   Duterte Boucher, D ^a   Nouel, D ^a   Costentin, J ^a  

^a CNRS   (France)

Author keywords

Dopamine uptake inhibition; GBR12783; Locomotor activity; Rat; Sensitization; D Trp11 neurotensin

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLALLYL)PIPERAZINE; NEUROTENSIN DERIVATIVE; NEUROTENSIN[11 DEXTRO TRYPTOPHAN];

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE UPTAKE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

ANIMALS; DOPAMINE UPTAKE INHIBITORS; INJECTIONS, INTRAVENTRICULAR; MALE; MOTOR ACTIVITY; NEUROTENSIN; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0029893453     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12531-3     Document Type: Article

References (14)

1. Bonnet, J.-J. and Costentin, J., GBR 12783, a potent and selective inhibitor of dopamine uptake: biochemical studies in vivo and ex vivo, Eur. J. Pharmacol., 121 (1986) 199-209.
2. Cador, M., Kelley, A.E., Le Moal, M. and Stinus, L., Behavioral analysis of the effect of neurotensin injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat, Psychopharmacology, 85 (1985) 187-196.
3. Duterte-Boucher, D., Kamenka, J.M. and Costentin, J., Comparison of the effects of three indirect dopamine agonists GK 13, GBR 12783 and dexamphetamine on behavioral tests involving central catechomaminergic transmissions, Psychopharmacology, 101 (1990) 344-353.
4. Elliott, P.J. and Nemeroff, C.B., Repeated neurotensin administration in the ventral tegmental area: effects on baseline and D-amphetamine-induced locomotor activity, Neurosci. Lett., 68 (1986) 239-244.
5. Horger, B.A., Taylor, J.R., Elsworth, J.D. and Roth, R.H., Preexposure to, but not cotreatment with, the neurotensin antagonist SR 48692 delays the development of cocaine sensitization, Neuropsychopharmacology, 11 (1994) 215-222.
6. Kalivas, P.W. and Taylor, S., Behavioral and neurochemical effect of daily injection with neurotensin into the ventral tegmental area, Brain Res., 358 (1985) 70-76.
7. Kalivas, P.W. and Stewart, J., Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity, Brain Res. Rev., 16 (1991) 223-244.
8. Kalivas, P.W. and Duffy, P., Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens, J. Neurosci., 10 (1990) 2940-2949.
9. Kasckow, J. and Nemeroff, C.B., The neurobiology of neurotensin: focus on neurotensin-dopamine interactions, Regul. Peptides, 36 (1991) 153-164.
10. Kitabgi, P., Neurotensin modulates dopamine neurotransmission at several levels along brain dopaminergic pathways, Neurochem. Int., 14 (1989) 111-119.
11. 11]neurotensin and dopamine transmission in rats, Eur. J. Pharmacol., 254 (1994) 263-269.
12. 11]NT, as well as neurotensin protected from inactivation by thiorphan, modifies locomotion in rats in a biphasic manner, Peptides, 11 (1990) 551-555.
13. Pilotte, N.S., Mark, W.M., Sharpe, L.G., De Souza, E.B. and Dax, E.M., Chronic cocaine administration and withdrawal of cocaine modify neurotensin binding in rat brain, Synapse, 9 (1991) 111-120.
14. 3H]GBR12783, Eur. J. Pharmacol., 210 (1992) 77-84.